BioSpace News Archive

The Massachusetts Biotechnology Council (MassBio®) today announced its Value of Health series, a year-long initiative to help educate its membership – which is largely small to mid-sized biotechs – about the current and expected pricing and reimbursement environment they face when bringing new drugs to market.

Diplomat Pharmacy, Inc. announced that the Board of Directors has made certain equity awards to new chief financial officer and treasurer Dan Davison, effective April 8, 2019.

Judge Richard J. Leon of the U.S. District Court for the District of Columbia ruled Monday that AIDS Healthcare Foundation (AHF) may propose up to three witnesses to testify at an upcoming evidentiary hearing in opposition to the nearly $70 billion acquisition of Aetna by CVS Health Corp.

PCCA has named Cathy Hance, RPh, co-owner of Compound Care Rx Plus in Louisville, Kentucky, as the recipient of the 2019 Evelyn Timmons Advocacy Award.

Pomerantz LLP is investigating claims on behalf of investors of Zogenix, Inc..

Prospective Study of 1,420 Patients Showed Statistically Significant Reduction in Post-Operative Complications and 30-Day Hospital Readmission Rates

Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation and certain of its officers and directors.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of WellCare Health Plans, Inc. (“WCG” or the “Company”) (NYSE: WCG) in connection with the proposed acquisition of the Company by Centene Corporation (“Centene”) (NYSE: CNC).

AmeriLife, a national leader in developing, marketing and distributing annuity, life and health insurance solutions, today named Patrick J. “Pat” Fleming as Executive Vice President Product Innovation & Corporate Actuary.

As the Department of Health and Human Services continues to make progress against the opioid crisis, the FDA remains focused on striking the right balance between reducing the rate of new addiction by decreasing excessive exposure to opioids through rational prescribing, while still enabling appropriate access to treatment for patients living with serious pain.